Atopiclair is a new treatment that is designed to improve the symptoms and signs of many types of dermatitis. It is steroid-free, working instead by improving the local environment of the affected skin. Atopiclair is available as a cream and a lotion.

Atopiclair offers:

	Rapid relief of itch ("pruritus")
	Improvement of redness ("erythema")
	Reduction in area affected by atopic dermatitis
	Atopiclair does not contain any steroids or immunomodulators

Atopiclair may be considered a ‘hydrolipidic wound dressing’ in its mode of action. Although it is a cream, it acts like a dressing to improving the environment of the skin and improve the dermatitis. Because of this mode of action, Atopiclair is registered as a Medical Device in the EU and the USA.

Individual key ingredients have been combined with a moisturizing, emollient base that includes both lipid and water soluble moisturizers. These provide a deep and soothing replenishment of essential moisture to the skin for maximum benefit.

Atopiclair has demonstrated these clinical benefits in clinical studies.  For further details of these studies please see the following links or contact Sinclair Pharmaceuticals:

Atopic Dermatitis study in the European Journal of Dermatology

Contact Dermatitis study in Exogenous Dermatology

Summary
Atopiclair offers patients and clinicians an easy, steroid-free option for improving the symptoms and appearance of dermatitis.